Text-Only | Login

Navigation: Home

Navigation: About

Navigation: Topics

Navigation: Projects

Navigation: Membership

Navigation: Boards

Navigation: Events

Navigation: Reports


Search.
Return to top.




Return to top.


Contact Information.


Institute of Medicine
500 Fifth Street NW
Washington DC 20001
iomwww@nas.edu
tel: 202.334.2352
fax: 202.334.1412

Media Contact
(Journalists Only)

news@nas.edu
tel. 202.334.2138
fax: 202.334.2158

Staff Directory


Return to top.

Institute of Medicine.


Review of the Centers for Disease Control and Prevention's Smallpox Vaccination Program Implementation: Letter Report #4

Review of the Centers for Disease Control and Prevention's Smallpox Vaccination Program Implementation: Letter Report #4


Released On:   
August 12, 2003

Read and Purchase

Print   Email

In its fourth letter report, the Committee on Smallpox Vaccination Program Implementation makes several recommendations to the Centers for Disease Control and Prevention related to the integration of smallpox preparedness into overall public health preparedness, implementation of the President's policy on offering smallpox vaccine to members of the general public who insist on receiving it, and selected aspects of overall smallpox vaccination program implementation.

The committee offers five key messages in this report:

  1. Smallpox is not the only threat to the public's health, and vaccination is not the only tool for smallpox preparedness. 
  2. To improve smallpox preparedness, it is essential to plan, train to the plan, exercise to the plan, and revise the plan.
  3. Vaccinating members of the general public beyond the key personnel states deem necessary for preparedness should proceed only under the aegis of smallpox vaccine clinical research trials or other well-structured clinical arrangements that meet the basic requirements of medical and public health ethics.
  4. The safety system appears to be working well to date, but CDC and its partners should remain vigilant to ensure the continuing safe implementation of the program. 
  5. The development of a research agenda for the smallpox vaccination program is important to ensuring the long-term success of smallpox preparedness efforts, as well as providing useful information for overall public health preparedness.


Related Reports
The Smallpox Vaccination Program: Public Health in an Age of Terrorism The Smallpox Vaccination Program: Public Health in an Age of Terrorism
Mar 3, 2005
Review of the Centers for Disease Control and Prevention Review of the Centers for Disease Control and Prevention's Smallpox Vaccination Program Implementation: Letter Report #6
Jul 6, 2004
Review of the Centers for Disease Control and Prevention Review of the Centers for Disease Control and Prevention's Smallpox Vaccination Program Implementation: Letter Report #5
Dec 19, 2003
Review of the Centers for Disease Control and Prevention Review of the Centers for Disease Control and Prevention's Smallpox Vaccination Program Implementation: Letter Report #3
May 27, 2003
Review of the Centers for Disease Control and Prevention Review of the Centers for Disease Control and Prevention's Smallpox Vaccination Program Implementation: Letter Report #2
Mar 27, 2003
Review of the Centers for Disease Control and Prevention Review of the Centers for Disease Control and Prevention's Smallpox Vaccination Program Implementation: Letter Report #1
Jan 17, 2003


Last Updated: 5/26/2005, 02:50 PM RSS





Home | About | Topics | Projects| Memberships| Boards | Events | Reports | Sitemap
The logo of the National Acadamies. This link goes to www.nationalacademies.org.
Return to top.

Copyright © 2008 National Academy of Sciences. All rights reserved.

Terms of Use and Privacy Statement